Literature DB >> 12797726

Implementation of a telemonitoring system for the control of an EEG-based brain-computer interface.

Gernot R Müller1, Christa Neuper, Gert Pfurtscheller.   

Abstract

By the use of a brain-computer interface (BCI), it is possible for completely paralyzed patients, who have lost their ability to speak, to have a new possibility to communicate with their environment. The training with such a BCI system can be performed at the patient's home, if there is a responsible person present who is familiar with the system. This person has to adjust different parameters and to adapt the training individually to each patient. Since this function is usually taken over by the developers of the system, the number of patients who can be included in regular BCI training is restricted due to geographical distances. This paper describes the implementation of a telemonitoring system, which makes it possible for the developer to control and supervise the BCI training from his or her own place of work. First experiences with a patient living far away from the developer's lab are reported.

Entities:  

Mesh:

Year:  2003        PMID: 12797726     DOI: 10.1109/TNSRE.2003.810423

Source DB:  PubMed          Journal:  IEEE Trans Neural Syst Rehabil Eng        ISSN: 1534-4320            Impact factor:   3.802


  2 in total

1.  Change in brain activity through virtual reality-based brain-machine communication in a chronic tetraplegic subject with muscular dystrophy.

Authors:  Yasunari Hashimoto; Junichi Ushiba; Akio Kimura; Meigen Liu; Yutaka Tomita
Journal:  BMC Neurosci       Date:  2010-09-16       Impact factor: 3.288

Review 2.  Brain Computer Interface on Track to Home.

Authors:  Felip Miralles; Eloisa Vargiu; Stefan Dauwalder; Marc Solà; Gernot Müller-Putz; Selina C Wriessnegger; Andreas Pinegger; Andrea Kübler; Sebastian Halder; Ivo Käthner; Suzanne Martin; Jean Daly; Elaine Armstrong; Christoph Guger; Christoph Hintermüller; Hannah Lowish
Journal:  ScientificWorldJournal       Date:  2015-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.